Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic response.
暂无分享,去创建一个
M. Ychou | P. Rouanet | F. Viret | J. Delpero | V. Moutardier | O. Turrini | D. Azria | M. Giovannini | L. Moureau-Zabotto | P. Rouanet